Clinical outcomes of catheter ablation for atrial fibrillation, atrial flutter, and atrial tachycardia in wild-type transthyretin amyloid cardiomyopathy: a proposed treatment strategy for catheter ablation in each arrhythmia.
Hisanori KanazawaSeiji TakashioTadashi HoshiyamaMiwa ItoShozo KanekoTakuya KiyamaYusei KawaharaHitoshi SumiYuichiro TsurutaNaoto KuyamaKyoko HirakawaMasanobu IshiiNoriaki TabataKenshi YamanagaKoichiro FujisueShinsuke HanataniDaisuke SuetaYuichiro ArimaSatoshi ArakiYasushi MatsuzawaHiroki UsukuTaishi NakamuraEiichiro YamamotoHirofumi SoejimaKenichi MatsushitaKenichi TsujitaPublished in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2024)
The outcomes of CA for ATTRwt-CM were acceptable, except for multiple focal AT and complex AFL. Catheter ablation may be aggressively considered as a treatment strategy with the expectation of improving mortality and hospitalization for HF.
Keyphrases
- catheter ablation
- atrial fibrillation
- left atrial
- left atrial appendage
- wild type
- oral anticoagulants
- heart failure
- direct oral anticoagulants
- percutaneous coronary intervention
- acute coronary syndrome
- type diabetes
- left ventricular
- cardiovascular disease
- risk factors
- combination therapy
- mitral valve
- replacement therapy